SynthesisFrontiers in oncology2026
Prevalence of depression among breast cancer patients in Asia: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While breast cancer (BC) patients face a heightened risk of depression, regional variations in prevalence within Asia remain underexplored. This study aimed to systematically review and meta-analyze the prevalence of depression among BC patients in Asia, and to explore variations by region and treatment modality. Methods: We searched multiple databases (e.g., PubMed, Embase, CNKI) for studies reporting depression prevalence in Asian adult BC patients up to May 2025. Inclusion required the use of standardized diagnostic or validated screening tools. Data extraction and quality assessment followed standard systematic review procedures. Pooled prevalence estimates were derived using a random-effects model in R software. Results: The meta-analysis revealed that the pooled prevalence of depression among Asian breast cancer patients was 28% (95% CI: 0.20-0.36). However, subgroup analyses were inconclusive regarding differences by region or treatment, likely due to limited representation within each subgroup. Conclusions: The findings suggest a high incidence of depression in breast cancer patients, underscoring the importance of integrating psychological interventions into their treatment plans. However, as analyses for regional or treatment-related differences were inconclusive, future research-particularly with larger samples from diverse settings-is needed to clarify these associations and better inform the development of tailored intervention strategies for BC patients across diverse Asian regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.